Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Vaccines
Research from University of Antwerp, Center for the Evaluation of Vaccination yields new data on vaccines
December 3rd, 2008
A report, 'Funding of drugs: do vaccines warrant a different approach,' is newly published data in Lancet Infectious Diseases. According to recent research from Antwerp, Belgium, "Vaccines have features that require special consideration when assessing their cost-effectiveness. These features are related to herd immunity, quality-of-life losses in young children, parental care and work loss, time preference, uncertainty, eradication, macroeconomics, and tiered pricing." "Advisory committees on public funding for vaccines, or for pharmaceuticals in general, should be knowledgable about these special features. We discuss key issues and difficulties in decision...
Source: Vaccine Weekly (2008-12-03)
|
